by B. Davies
Cerebrolysin® is a mixture of amino acids (think of these as essential ingredients for all human processes) and small proteins, thought to stimulate neural growth. The compound is marketed by Ever Pharma  and has a reasonable safety profile and has been tried in a range of neurological conditions including Stroke and Alzheimer’s Dementia, as well as our very own CSM!
Where's the proof?
So, experimental proof lies in research conducted in Egypt , where the scientists took patients with mild CSM and at random, gave half of the patients Cerebrolysin® and half a placebo, and followed the patients over 6 months . No patients in this series received surgery. They found that patients taking Cerebrolysin® were more likely to show improvement in their CSM after 6 months, and more likely to show a greater amount of improvement.
What's the catch?
There are a number of cautions that must be attached to these results:
However, these results are interesting. Cerebrolysin ® has shown promise in animal studies and some human studies; and just because clear efficacy has not yet been shown in humans yet, does not mean it isn’t of benefit.
So, a small study, with limitations, but of interest! We look forward to seeing further developments in this area; who knows, this could turn out to be a wonder drug! Comment down below if you wish to share your experience with this drug, or any others you've found helpful in dealing with CSM symptoms.
Next week, we're going to tell you more about what sort of factors doctors might look for in imaging studies to decide whether CSM is going to be symptomatic or not - stay tuned!!
The latest expert and patient articles